MEDIUM confidence: 100% data completeness, but the composite (58) sits in the indecisive 30–70 range — strong-buy and short calls require a more decisive composite. What does confidence mean?
Technical context for active traders — derived from price, the 50/200-day moving averages, the 52-week range, and recent volume. Not part of the QScore.
Dated events from the market calendar; the “also watch” items are AI-generated observations from QScoring data. Informational only — not investment advice, and dates can change.
AI classification of policy/regulatory sensitivity from the company's sector, industry, and business description. Exposure/sensitivity only — not a political opinion, a prediction of government action, or investment advice. As of 2026-07-10.
Fama-French 5-factor (2×3) + Momentum, monthly OLS with Newey-West errors. Bars show signed factor betas; faded bars/figures aren't statistically significant.
| Metric (USD) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $15.9B— | $19.8B+24.8% | $33.8B+70.7% | $39.6B+17.1% | $40.4B+2.2% |
| EPS (dil.) | $4.15— | $2.90-30.1% | $3.89+34.1% | $5.80+49.1% | $7.41+27.8% |
| Free Cash Flow | $1.6B— | $13.7B+745.5% | $4.7B-65.8% | -$782M-116.7% | $5.2Bn/m |
| Gross Margin | 100.0% | 81.6%-18.5pp | 51.4%-30.1pp | 46.0%-5.4pp | 48.9%+3.0pp |
| Operating Margin | 29.3% | 17.6%-11.7pp | 12.7%-4.9pp | 14.8%+2.1pp | 17.5%+2.7pp |
| Net Margin | 23.7% | 12.9%-10.8pp | 9.8%-3.1pp | 11.5%+1.7pp | 13.7%+2.3pp |
Absolute figures with year-over-year change. Margins show the level with the change in percentage points (pp). “n/m” = not meaningful (prior ≤ 0); ⚠ marks a large percentage off a small base — read the dollar figure.
Avg target $165 (last qtr, 11 analysts) → $172 (last mo, 7) (+3.8%).
Buy-rated share 56% → 56% over ~3 months (+0pp).
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jul 2026 | $2.23 | $2.46 | +10.3% |
| Apr 2026 | $1.96 | $2.25 | +14.8% |
| Jan 2026 | $1.91 | $2.02 | +5.8% |
| Oct 2025 | $1.76 | $1.91 | +8.5% |
| Jul 2025 | $1.75 | $1.94 | +10.9% |
| Apr 2025 | $1.50 | $1.58 | +5.3% |
| Jan 2025 | $1.53 | $1.56 | +2.0% |
| Oct 2024 | $1.41 | $1.52 | +7.8% |
Net insider -$11.5M over 180 days (0 open-market buys, 8 sells). Insider buying is the informative signal; routine selling is normal.
Short interest, days-to-cover, and institutional-ownership change require a data-plan upgrade (not yet available).
Forward-return IC, quintile spread & hit rate publish on /performance as the tracking panel accrues enough no-look-ahead history.
Working the DCF backward: holding the assumptions below, this is the free-cash-flow growth today's price implies over the next 10 years. It is a read on the price's embedded expectations — not a fair-value or target price.
The price implies FCF growth above the analyst consensus of 5.1%/yr (revenue basis).
Base free cash flow $3.0B (avg FY2023–FY2025; latest year $5.2B) · equity value $110.7B · levered FCF discounted at the cost of equity. Reverse DCF is illustrative, not advice.
Net buyback (repurchases less issuance) ÷ market cap, plus trailing dividend yield.
The QScore of 58 for BNY indicates a moderately attractive stock, with the short-term score of 62 exceeding the long-term score of 55 by 7 points. BNY scores high on momentum, driven by a 12-month return of 55.5% and a bullish 50-day versus 200-day moving average trend. The stock's value and profitability scores are more subdued, with a P/E of 18.7 and ROE of 14.2%, while its risk score is elevated due to 60-day volatility of 22.9%.